The sad story of Vioxx, and what we should learn from it

Article Type

Article

Changed

Tue, 10/09/2018 - 09:57

Display Headline

The sad story of Vioxx, and what we should learn from it

Author(s)

Juhana Karha, MD

Eric J. Topol, MD

Article PDF

content_71_933.pdf

Author and Disclosure Information

Juhana Karha, MD
Department of Cardiovascular Medicine, The Cleveland Clinic Foundation

Eric J. Topol, MD
Chairman, Department of Cardiovascular Medicine, The Cleveland Clinic Foundation

Address: Eric J. Topol, MD, Chairman, Department of Cardiovascular Medicine, F25, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail topole@ccf.org

Issue

Cleveland Clinic Journal of Medicine - 71(12)

Publications

Cleveland Clinic Journal of Medicine

Topics

Drug Therapy

Rheumatology

Page Number

933-934, 936, 938-939

Sections

Author(s)

Author(s)

Author and Disclosure Information

Juhana Karha, MD
Department of Cardiovascular Medicine, The Cleveland Clinic Foundation

Eric J. Topol, MD
Chairman, Department of Cardiovascular Medicine, The Cleveland Clinic Foundation

Address: Eric J. Topol, MD, Chairman, Department of Cardiovascular Medicine, F25, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail topole@ccf.org

Author and Disclosure Information

Juhana Karha, MD
Department of Cardiovascular Medicine, The Cleveland Clinic Foundation

Eric J. Topol, MD
Chairman, Department of Cardiovascular Medicine, The Cleveland Clinic Foundation

Address: Eric J. Topol, MD, Chairman, Department of Cardiovascular Medicine, F25, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail topole@ccf.org

Article PDF

content_71_933.pdf

Article PDF

content_71_933.pdf

Issue

Cleveland Clinic Journal of Medicine - 71(12)

Issue

Cleveland Clinic Journal of Medicine - 71(12)

Page Number

933-934, 936, 938-939

Page Number

933-934, 936, 938-939